Primary Hyperaldosteronism
Primary Hyperaldosteronism is the indication for 2 drugs in DrugBank. It is covered by 4 curated, structured indications.
- Also known as
- Conn Syndrome · Conn's Syndrome · Conns Syndrome
- Indicated drugs
Resolves to
Vocabularies
What you can answer from here — as of October 22, 2026
2Indicated drugsWith each drug's targets and mechanismListed above
4Structured indicationsPopulation, line of therapy, route and combination as fields, not proseSign in
Which approved drugs for Primary Hyperaldosteronism share a target, and which companies have late-stage candidates against it?
Create a free account or log in to explore the full data card.
Create Account